Ceeto Capital Group, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ceeto Capital Group, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$330,000
-38.0%
44,000
-25.4%
0.14%
-44.6%
Q3 2021$532,000
-33.7%
59,000
-11.9%
0.25%
-31.0%
Q2 2021$802,000
-13.5%
67,000
-9.5%
0.36%
-20.3%
Q1 2021$927,000
-25.7%
74,000
-7.5%
0.45%
-28.1%
Q4 2020$1,248,000
+58.2%
80,000
-4.2%
0.63%
+42.9%
Q3 2020$789,000
+5.5%
83,5000.0%0.44%
-9.1%
Q2 2020$748,000
+134.5%
83,500
+67.0%
0.48%
+89.5%
Q1 2020$319,000
+0.3%
50,000
+31.6%
0.26%
+23.1%
Q4 2019$318,000
-7.6%
38,0000.0%0.21%
-16.5%
Q3 2019$344,000
-15.9%
38,0000.0%0.25%
-17.3%
Q2 2019$409,000
+4.6%
38,000
-7.3%
0.30%
+4.9%
Q1 2019$391,000
-35.7%
41,000
-22.6%
0.29%
-42.8%
Q4 2018$608,000
-32.3%
53,0000.0%0.50%
-18.5%
Q3 2018$898,000
+21.7%
53,000
+1.9%
0.62%
+11.4%
Q2 2018$738,000
-99.9%
52,000
+13.0%
0.55%
-16.6%
Q1 2018$874,000,00046,0000.66%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders